(Reuters) – Warren Buffett’s Berkshire Hathaway Inc <BRKa.N> said on Monday it has begun investing in four large drugmakers.
In a regulatory filing detailing its U.S.-listed investments as of Sept. 30, Berkshire disclosed new stakes in Abbvie Inc <ABBV.N>, Bristol-Myers Squibb Co <BMY.N>, Merck & Co <MRK.N> and Pfizer Inc <PFE.N>. Berkshire also revealed a new stake in T-Mobile US Inc <TMUS.O>.
Investors monitor Omaha, Nebraska-based Berkshire’s quarterly filings to see where Buffett and his portfolio managers Todd Combs and Ted Weschler see value.
(Reporting by Jonathan Stempel in New York; Editing by Chris Reese)

The post Buffett’s Berkshire invests in several big drugmakers appeared first on Morningology.